EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A luminal non‐coding RNA‐based genomic classifier confirms favourable outcomes in patients with clinically organ‐confined bladder cancer treated with radical cystectomy

Joep J de Jong iD, James A Proudfoot, Siamak Daneshmand, Robert S Svatek, Vikram Narayan, Ewan A Gibb, Elai Davicioni, Shreyas Joshi, Aaron Dahmen, Roger Li iD, Brant A Inman iD, Paras Shah und 3 weitere

BJU International · 2025

DOI: 10.1111/bju.16572 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJU International, 2025. Verfasst von Joep J de Jong und 14 weiteren Autor:innen. Beteiligte Einrichtung: Erasmus University Medical Center, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Cystectomy, RNA, Long Noncoding, Carcinoma, Transitional Cell. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Wilson Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To further evaluate a genomic classifier (GC) in a cohort of patients undergoing radical cystectomy (RC), as long non‐coding RNA (lncRNA)‐based genomic profiling has suggested utility in identifying a distinct tumour subgroup corresponding to a favourable prognosis in patients with bladder cancer. Patients and Methods Transcriptome‐wide expression profiling using Decipher Bladder was performed on transurethral resection of bladder tumour samples from a cohort of patients with high‐grade, clinically organ‐confined (cTa–T2N0M0) urothelial carcinoma (UC) who subsequently underwent RC without any neoadjuvant therapy ( n = 226). The lncRNA‐based luminal favourable status was determined using a previously developed GC. The primary endpoint was overall survival (OS) after RC. Secondary endpoints included cancer‐specific mortality and upstaging at RC.

Results

In the study, 134 patients were clinical non‐muscle‐invasive bladder cancer (cTa/Tis/T1) and 92 patients were cT2. We identified 60 patients with luminal favourable subtype, all of which showed robust gene expression patterns associated with less aggressive bladder cancer biology. On multivariate analysis, patients with the luminal favourable subtype (vs without) were significantly associated with lower odds of upstaging to pathological (p)T3+ disease (odds ratio [OR] 0.32, 95% confidence interval [CI] 0.12–0.82; P = 0.02), any upstaging (OR 0.41, 95% CI 0.20–0.83; P = 0.01), and any upstaging and/or pN+ (OR 0.50, 95% CI 0.25–1.00; P = 0.05). Luminal favourable bladder cancer was significantly associated with better OS (hazard ratio 0.33, 95% CI 0.15–0.74; P = 0.007).

Conclusions

This study validates the performance of the GC for identifying UCs with a luminal favourable subtype, harbouring less aggressive tumour biology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsCystectomyRNA, Long NoncodingCarcinoma, Transitional CellHumansMaleFemaleAgedMiddle AgedGene Expression ProfilingPrognosisTreatment OutcomeAged, 80 and over

Stichwörter der Autor:innen

bladder cancergene expression profilingluminal favourablemolecular subtypingradical cystectomy

Substanzen

RNA, Long Noncoding

Autor:innen und Institutionen

  • Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Veracyte Inc., San Francisco, CA, USA.
  • Department of Urology, USC/Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
  • University of Texas Health San Antonio, San Antonio, TX, USA.
  • Emory University School of Medicine, Atlanta, GA, USA.
  • Moffitt Cancer Center, Tampa, FL, USA.

ORCID-Profile: Joep J de Jong, Roger Li, Brant A Inman, Yair Lotan

Förderung

  • Wilson Foundation

Zitieren

APA

de Jong, J. J., Proudfoot, J. A., Daneshmand, S., Svatek, R. S., Narayan, V., Gibb, E. A., Davicioni, E., Joshi, S., Dahmen, A., Li, R., Inman, B. A., Shah, P., Chaplin, I., Wright, J., & Lotan, Y. (2025). A luminal non‐coding RNA‐based genomic classifier confirms favourable outcomes in patients with clinically organ‐confined bladder cancer treated with radical cystectomy. BJU International. https://doi.org/10.1111/bju.16572

Vancouver

de Jong JJ, Proudfoot JA, Daneshmand S, Svatek RS, Narayan V, Gibb EA, et al. A luminal non‐coding RNA‐based genomic classifier confirms favourable outcomes in patients with clinically organ‐confined bladder cancer treated with radical cystectomy. BJU International. 2025. doi:10.1111/bju.16572

BibTeX
@article{deJong2025,
  author = {de Jong, Joep J and Proudfoot, James A and Daneshmand, Siamak and Svatek, Robert S and Narayan, Vikram and Gibb, Ewan A and Davicioni, Elai and Joshi, Shreyas and Dahmen, Aaron and Li, Roger and Inman, Brant A and Shah, Paras and Chaplin, Iftach and Wright, Jonathan and Lotan, Yair},
  title = {A luminal non‐coding RNA‐based genomic classifier confirms favourable outcomes in patients with clinically organ‐confined bladder cancer treated with radical cystectomy},
  journal = {BJU International},
  year = {2025},
  doi = {10.1111/bju.16572}
}
Kostenlos starten →